Scientific Committee National - Clinical Lipidology 2025

scientific committee

NATIONAL (AUSTRIA)

Martin Clodi

University Professor
Specialist in Internal Medicine
Head of the Internal Medicine Department, BHB Linz

Florian Kronenberg

Head of Institute of Genetic Epidemiology

Florian Kronenberg

Florian Kronenberg received his MD from the University of Innsbruck, Austria. After his training in Medical Genetics in Gerd Utermann's lab, he worked with Roger R. Williams and Steve Hunt at the University of Utah, USA. Later, he headed the Research Unit "Genetic Epidemiology" at the Helmholtz-Center Munich. In 2004, he became full professor and head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck. He is a Member of the Academia Europaea.

His main research interests are genetic and clinical epidemiological studies on lipoprotein(a) as one of the most important genetic risk factors for cardiovascular disease. His team has probably the largest collection of samples with more than 40.000 individuals with in depth characterization of the LPA gene including data from Western blot analyses.

He is Co-Editor of "Atherosclerosis" and served as workgroup member on several guideline and consensus initiatives (K/DOQI, KDIGO and EAS). He chaired the most recent EAS Consensus Statement on Lp(a) (together with Samia Mora and Erik Stroes).

Florian Kronenberg has published roughly 500 papers including 400 original papers and about 90 review articles, editorials and book chapters. He has an H-index of 96 (Scopus) and 112 (Google Scholars) with roughly 51,000 citations.

Read Full Bio

Walter Speidl

Clinical cardiologist and intensivist at the Medical University of Vienna in Austria

Walter Spedil

Associate Professor Dr. Walter Speidl is clinical cardiologist and intensivist at the Medical University of Vienna in Austria. He started his residency at the Medical University of Vienna in 2003 and was research fellow at the Mount Sinai School of Medicine, New York from 2006 to 2008. In 2014 he finished his clinical fellowships for cardiology and for intensive care medicine. He is working as deputy chair of the medical intensive care unit and as interventionist. In 2018 he founded a dedicated cardiac lipid clinic to improve secondary prevention of high-risk patients and is its head since then. His clinical research focuses on lipids and biomarkers of inflammation and thrombosis in stable coronary artery disease and acute coronary syndromes. In addition, he devotes his time on basic research regarding the interplay of innate immunity and thrombosis in critical ill patients and in the pathogenesis of atherosclerosis and acute coronary events.

Read Full Bio

Christoph Binder

Professor at Medical University of Vienna

Prof. Christoph Binder

Professor of Atherosclerosis Research

Department of Laboratory Medicine

Medical University of Vienna, Austria

Christoph J. Binder (born 1973) received his MD degree from the University of Vienna, Austria, in 1997 and his PhD degree in Molecular Pathology from the University of California San Diego (UCSD), USA, in 2002. Following postdoctoral training at the Department of Medicine of UCSD, he established his own research group at the Department of Laboratory Medicine of the Medical University of Vienna in 2005. In 2009, he was appointed Full Professor of Atherosclerosis Research at the Medical University of Vienna. He is a specialist in Laboratory Medicine and currently Deputy Head of the Department of Laboratory Medicine at the Medical University of Vienna. Between 2006 until 2021 he was Principal Investigator at the Center for Molecular Medicine of the Austrian Academy of Sciences. Christoph Binder’s research interests span the interface of vascular biology, lipid oxidation, and immunity. His group is investigating immune mechanisms of atherosclerosis with a special focus on the role of innate and humoral immunity and how this can be exploited for the treatment of cardiovascular disease. Christoph Binder has won numerous prestigious fellowships and awards and has authored >200 original and review papers in important international journals, including Nature and Nature Medicine. He is Co-Editor of Atherosclerosis and Section Editor of Thrombosis & Haemostasis, and since 2017 PI of the Austrian Familial Hypercholesterolemia Registry. Since 2024 he acts as Vice President for Biology and Medicine of the Austrian Science Fund.

Read Full Bio